Nanosensor based approaches for quantitative detection of heparin.

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Nanotechnology

Background:

• Heparin is a crucial anticoagulant, but its complex structure and low concentrations challenge precise clinical monitoring.
• Conventional assays for heparin detection lack the required sensitivity and specificity, posing risks like thrombocytopenia.
• Developing advanced detection methods is vital for ensuring patient safety and heparin product quality.

Purpose of the Study:

• To review various nanosensor-based approaches for sensitive and selective heparin detection.
• To explore the integration of nanosensors with smart-phone technology for point-of-care diagnostics.
• To discuss the role of emerging technologies like AI and ML in improving heparin quality assurance.

Main Methods:

• Review of colorimetric, fluorometric, SERS, and electrochemical sensing techniques utilizing nanomaterials.
• Exploration of smartphone-integrated nanosensors for portable diagnostics.
• Analysis of recent advancements in nanopore technologies, AI, and ML for contaminant detection.

Main Results:

• Nanosensors demonstrate enhanced sensitivity and selectivity for detecting heparin at low concentrations.
• Smartphone integration enables potential for rapid, point-of-care heparin testing.
• AI and ML show promise in identifying specific contaminants in heparin formulations.

Conclusions:

• Nanosensors represent a significant advancement over conventional methods for heparin analysis.
• The integration of advanced technologies offers a pathway to more reliable and economical heparin quality control.
• Improved heparin detection methods are essential for enhancing patient safety and clinical outcomes.